ABCB1 and neoplasm: Furthermore, previous literature has confirmed that anticancer drugs, such as adriamycin and other chemicals, can damage tumor cell DNA, which can lead to the activation of NF-κB. Activated NF-κB promotes the transcription of mdr-1 via NF-κB binding sites.